Laura Chambers

From poo to promise: Fecal microbiota transplants support immunotherapy resensitization in solid tumors @LAURAJMOULTON @SciBehindSciPod @dspakowicz highlight work showing FMT improves anti-PD-1 inhibitor efficacy in unresectable or metastatic solid cancers cell.com/cell-host-micr…

Had a great time the other evening with my incredible partnersat @OSUCCC_James - @FBackesMD and @LAURAJMOULTON discussing the incredible advances in our care of patients with gynecological malignancies @OncLive #SOSS

Excited to have many clinical trial opportunities for our patients and proud to be leading accrual for GOG foundation trials nationally @OSUCCC_James @osugynonc #NRG2024 #GOGF #GOGPARTNERS

Excited to share our work about impact of antibiotics and PPI on endometrial cancer patients @dspakowicz @omalleygynonc @OSUCCC_James

#Editorial The inclusion of patient perspectives & timely management of toxicity in these guidelines should be applauded 👏 👏 By @mollyymorton 🔗 bit.ly/3P0VNe1 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @OncoAlert @IJGCfellows

Type 2 diabetes diagnoses in the perioperative and survivorship periods following surgical management of endometrial cancer @mollyymorton @LAURAJMOULTON @SGO_org @IGCSociety @ESGO_society @ASCO @OncoAlert sciencedirect.com/science/articl…

Thanks @gynoncjnls for helping us share our work! @LAURAJMOULTON Prevalence of type 2 diabetes diagnoses in the perioperative and survi... sciencedirect.com/science/articl…

Thank you to @greenjrnl, @LAURAJMOULTON for supporting this project - clinical trials improve outcomes for our patients! pubmed.ncbi.nlm.nih.gov/37535957/

A labor of love (and physiology) with @LAURAJMOULTON @OSUCCC_James Malnutrition, sarcopenia, and cancer cachexia in gynecologic cancer sciencedirect.com/science/articl…

Proud of this important work by @MollyMorton17 @OSUCCC_James “More than a song and dance”: Exploration of patient perspectives and ... sciencedirect.com/science/articl…

The modified 5-item frailty index is a predictor of post-operative complications in #VulvarCancer @LAURAJMOULTON @kbixelMD 🔗bit.ly/3KpW9Z8 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @OncoAlert @IJGCfellows @GynMe4

Excellent presentation by Dr Molly Morton on the importance of clinical trials. Trial patients do better and live longer. @SGO_org #swedishcancerinstitute

Excellent opening session presentation by @osugynonc fellow @MollyMorton17 on improved OS with clinical trial participation in platinum resistant OC @SGO_org @CleObGynTracks

AddThis | Home authors.elsevier.com/sd/article/S00… Now part of NCCN guidelines for PROC. Earlier opportunity to gain access for patients in patients with PSOC (GOG 3078; GLORIOSA). @OSUCCC_James @GOG.

Dr O'Malley @omalleygynonc discussing the exciting GOG/NRG portfolio on ovarian cancer clinical trials @NRGonc @OSUCCC_James

My amazing partner @kbixelMD giving updates on ROCC trial @leitaomd @OSUCCC_James @osugynonc @NRGonc @omalleygynonc

@GOG exciting discussion of cervical cancer clinical trial portfolio! @NRGonc @kbixelMD @OSUWexMed @OSUCCC_James

@FBackesMD and @GynCancerMD discussing @GOG endometrial cancer clinical trials and practice changing updates! @OSUCCC_James @osugynonc @NRGonc @omalleygynonc

Join me in attending The GOG Foundation, Inc. Dinner Meeting on Thursday, January 26th from 6:30 pm – 9:30 pm ET. For more information on this event for participating sites, go to gog.org/event/the-gog-……. #clinicaltrials #GynecologicOncology #GOGPartners #GOGF @GOG @NRGonc

An intact #microbiome functions as a tumor suppressor in #OvarianCancer, and antibiotics perturb gut microbiota to promote tumor growth and suppress cisplatin sensitivity. bit.ly/3O1Kr8s @oreizes @LAURAJMOULTON @OSUWexMed